GSK & AstraZeneca face corruption investigation—hospitality lavished on those who prescribe drugs could constitute bribery
U.K. pharmaceutical firms GlaxoSmithKline PLC and AstraZeneca PLC are facing a corruption investigation in the U.S. over claims that the hospitality lavished on those who prescribe their treatments could constitute bribery, The Independent newspaper in London reported Saturday, without citing sources.
SHARE YOUR STORY/COMMENT: